Alpha DNA Investment Management’s Lowe's Companies LOW Stock Holding History
Bought
Maintained
Sold
Other funds holding LOW
PSCM
Alpha DNA Investment Management's LOW Position: Q2 2022 in Review
Alpha DNA Investment Management sold out of Lowe's Companies (LOW) in Q2 2022, closing a stake of 6,079 shares — an estimated $1.23M sold.
Alpha DNA Investment Management first reported a position in LOW in Q4 2020 and held it in 4 quarters. The position peaked at $1.84M in Q2 2021. 2,167 funds tracked by Wall St. Rank hold LOW as of Q2 2022.
- Alpha DNA Investment Management reported no remaining Lowe's Companies position as of Q2 2022 after selling out during the quarter.
- Alpha DNA Investment Management sold 6,079 Lowe's Companies shares in Q2 2022, an estimated $1.23M.
- Alpha DNA Investment Management first reported a position in Lowe's Companies in Q4 2020 and held it in 4 quarters.
- Alpha DNA Investment Management's Lowe's Companies position peaked at $1.84M in Q2 2021.
- 2,167 funds tracked by Wall St. Rank held Lowe's Companies as of Q2 2022.
Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.